July 12, 2025) - Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit -- captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) -- seeks to represent ...

This was the stock's second consecutive day of losses.

Centene's stock plunge offers a potential long-term opportunity. Click here for a full investment analysis of CNC stock.

Intel shares jumped Tuesday following news the embattled chipmaker plans to slash hundreds of jobs as part of previously ...

Nearly a week ago, shares of Centene closed down 40.4%, making it the largest single-day drop since the company went public ...

CoreWeave stock slipped after the Nvidia partner said it will acquire Core Scientific in an all-stock deal valued at around ...

UnitedHealth, Centene, and Elevance suffered steep market cap losses amid earnings guidance withdrawals and potential Medicaid changes tied to new legislation.

In a report released today, Timothy Arcuri from UBS maintained a Hold rating on Intel, with a price target of $21.00. The company’s shares closed yesterday at $21.88. Take advantage of TipRanks ...

Centene announced it was scrapping its full-year financial forecast after discovering fewer people were signing up for ...

Centene shares plummeted Wednesday after the managed-care company withdrew its full-year outlook after receiving new data ...

The S&P 500 was up 0.3% in afternoon trading and on track to set a record for the third time in four days. The Dow Jones ...

CNBC’s Jim Cramer gave his take Centene and the broader health insurance space after shares plummeted on Wednesday.